Hoth Therapeutics, Inc. (HOTH) SEC Filings — 2025
18 SEC filings for Hoth Therapeutics, Inc. (HOTH) in 2025.
Filings
- Hoth Therapeutics' Losses Widen Amid Soaring R&D Costs — 10-Q · Nov 12, 2025
- Hoth Therapeutics Files 8-K — 8-K · Oct 17, 2025
- Hoth Therapeutics Files 8-K: Other Events Reported — 8-K · Sep 12, 2025
- Hoth Therapeutics Files 8-K on Officer/Director Changes — 8-K · Aug 22, 2025
- Hoth Therapeutics Files 10-Q, Remains Pre-Revenue Biotech — 10-Q · Aug 12, 2025
- Hoth Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Aug 5, 2025
- Hoth Therapeutics, Inc. 8-K Filing — 8-K · Jun 24, 2025
- Hoth Therapeutics Files 8-K — 8-K · Jun 20, 2025
- Hoth Therapeutics Seeks 183% Boost in Equity Incentive Plan Shares — DEF 14A · Jun 16, 2025
- Hoth Therapeutics Files 8-K — 8-K · Jun 9, 2025
- Hoth Therapeutics Faces Delisting Concerns — 8-K · May 16, 2025
- Hoth Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
- Hoth Therapeutics Files 8-K: Other Events — 8-K · May 2, 2025
- Hoth Therapeutics Announces Board Changes and Officer Compensation — 8-K · Apr 15, 2025
- Hoth Therapeutics Files 2024 Annual Report — 10-K · Mar 28, 2025
- Hoth Therapeutics Files 8-K: Material Agreement & Financial Restatement — 8-K · Mar 25, 2025
- Hoth Therapeutics Files 8-K — 8-K · Feb 7, 2025
- Hoth Therapeutics Files 8-K — 8-K · Jan 24, 2025